Patient Characteristics and Pre-Infusion Biomarkers of Inflammation Correlate with Clinical Outcomes after Treatment with the Defined Composition, CD19-Targeted CAR T Cell Product, JCAR017
Year: 2017
Type: article
Source: Blood
Institutions: City Of Hope National Medical Center, City of Hope, Massachusetts General Hospital, Juno Therapeutics (United States), Memorial Sloan Kettering Cancer Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Nebraska Medical Center, Beth Israel Deaconess Medical Center, Harvard University, The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, Fred Hutch Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2971343315